Palaamon Crowdfunding

Palaamon Crowdfunding

Created using Figma
To produce new innovative drugs, the pharmaceutical industry employs hundreds of thousands of Data Science experts.
How do these experts spend their time?
80% at installing and configuring computers, software and libraries
Can Data Science results be reproduced easily?
NO! Most complex analysis workflows are impossible to reproduce

Palaamon is a platform that streamlines and speeds the process of analyzing complex datasets using cutting-edge containerization and distributed ledger technologies.

Palaamon's technology finally solves the thorny problem of reproducibility, crucial for Pharmaceutical Research and Development.

Until now original research has been difficult to reproduce, and thus verify, because any variation in the original technical configuration can negatively affect reproducibility over time.

Palaamon enables full transparency, immutability, and reproducibility, no matter the user's technical setup.
Jan 10, 2020
Jul 9, 2020
100% completed
Raised funds - no Data
past
Token Details
Ticker
PALCFT
Accepted Currencies
ETH
Company Details
Registered Country
Switzerland
Additional Details
Categories
Platform

About Palaamon Crowdfunding

Palaamon is a high-performance computing environment that distributes data analysis workflows across a cluster of computers, for highly scalable, virtually immutable and fully replicable results.

Palaamon enables researchers to reproduce workflows of analysis using well-tagged module containers. It traces all events of an analysis and records them to a distributed ledger. Every worker container, the code it runs, and all its dependencies are stored in Palaamon's registry to ensure ultimate reproducibility.

Palaamon is developed as a pure Reactive application using state-of-art technologies. Palaamon uses cryptographic hash functions at every level of processing to guarantee final traceability and reproducibility of workflows. Users of Palaamon are able to compare results of transforms based on similarity scores of Merkle trees. Palaamon provides a service to push results signatures to distributed ledgers.

Palaamon includes a marketplace that allows any developer, statistician, or data scientist to publish her code in any coding language to the platform and get rewarded in tokens when researchers license that algorithm. Coders and researchers mutually set the terms of use, which are then enshrined in smart contacts on the distributed ledger.

Palaamon Crowdfunding Roadmap

  • 2017

  • Palaamon Proof of Concept completed.
  • 2018

  • Palaamon Proof of Value completed on extended RNASeq data analysis workflow.
  • Q2 2019

  • Palaamon open source alpha v1.0 released.
  • Q3 2019

  • First official Palaamon's White Paper.
  • Read More
  • Q4 2019

  • Launching crowdfunding token PALCFT.
  • Q1 2020

  • Palaamon v1.0 beta released for UAT.
  • Q2 2020

  • PALCFT token crowdfunding ends.
  • Q3 2020

  • Palaamon Marketplace for Data Science Coders and Data scientists.
  • Q4 2020

  • First release of full fledged Palaamon SDK for data Science Coders.
  • Q1 2021

  • Scale-up of Palaamon to thousands of nodes.

Palaamon Crowdfunding Team

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Bernard Deffarges
CEO & Founder
unverified
Damien Hauser
Founder
unverified
Suzanne Studinger
Quality Assurance Lead
unverified
Randy Baron
Software Engineer
unverified
  • Due to potential time differences in information updates, please verify the accuracy of each ICO project through its official website or other official communication channels.
  • This information is not intended as a recommendation or suggestion for ICO investment. Please conduct thorough research on the relevant information and make your own informed decision regarding ICO participation.
  • If you identify any issues or errors in this content, or if you wish to submit your own ICO project for listing, please contact us via email at info@icoholder.com.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.